This Zoom webinar with Lynda Stuart from the Bill and Melinda Gates Foundation aired July 7, 2020, as the third program in the Vaccines in the Time of COVID-19 series. Watch a recording in the player above.
Vaccine producers around the world are already scaling up production of the raw materials needed to construct a COVID-19 vaccine to meet global demand. Part 3 of Vaccines in the Time of COVID-19 discusses how vaccines are produced and how that production is financed and distributed, including implications for equitable distribution.
Speaker: Lynda Stuart, Deputy Director, Vaccines and Human Immunobiology, Bill and Melinda Gates Foundation.
Moderator: Sabrina Sholts, Curator of Biological Anthropology at Smithsonian’s National Museum of Natural History.
Vaccines in the Time of COVID-19
Vaccines have been heralded as the holy grail of disease prevention in the 20th and 21st centuries, reducing infant mortality in improving life expectancy worldwide. As we navigate the present COVID-19 pandemic, government officials, scientists and economists urge that the path forward hinges on development of a safe and effective vaccine — with some even suggesting that one will be available in as little as a year.
Drawing upon the expertise of research scientists, federal agencies, and anthropologists, this four-part series demystified the production of vaccines. The series began with an insider’s perspective on research approaches, followed by presentations on safety and testing, approval, the supply chain, and issues of equity and access. This series was offered in conjunction with the exhibition Outbreak: Epidemics in a Connected World at the National Museum of Natural History.